Japanese scientists Shimon Sakaguchi and Susumu Kitagawa received the 2025 Nobel Prizes in Physiology or Medicine and Chemistry, respectively, at the award ceremony in Stockholm on Wednesday evening.
Hearing scheduled for Scripps Park sidewalk widening A city of San Diego hearing officer is scheduled to consider plans to ...
Killer cells (NK) are the guardians of the immune system, which play an important role in destroying pathogens, foreign ...
Natural killer (NK) cells are the bodyguards of our immune system. As a first line of defense, they destroy invading pathogens, foreign bodies, and infected cells in early stages, thereby preventing ...
That’s just the ones who are diagnosed. Many more have undiagnosed autoimmune reactions and are the most misdiagnosed and overlooked patient population.
Adjuvants help boost the immune response to the antigen in the vaccine, and can also help with dose sparing, according to a recent review published in Pediatrics. The most common adjuvants are ...
Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, ...
Today's biomedical researchers are relentlessly searching for genes that drive disease, with the goal of creating therapies ...
VTP-1000 is an investigational, injectable antigen-specific tolerance immunotherapy that utilizes Barinthus Bio’s proprietary SNAP-TI platform to co-deliver multiple gluten-derived peptide antigens ...
Global News - Inquirer.net on MSN

Nobel winner Sakaguchi aims for effective cancer treatment

Japanese researcher Shimon Sakaguchi, one of the three winners of this year’s Nobel Prize in Physiology or Medicine, has ...
Ocular immunology investigates the complex interplay between molecular mediators and immune cells responsible for maintaining ocular immune privilege, as ...
A new analysis from the Paul Ehrlich Institute (PEI) and University Medical Center Freiburg, Freiburg, Germany, showed that only certain influenza A virus (IAV) strains trigger life-threatening ...